@FierceBiotech: Biotech bad boy Martin Shkreli faces a new set of angry foes: federal prosecutors. News | Follow @FierceBiotech
@JohnCFierce: Gilead steps in to replace AbbVie with $2B Galapagos collaboration. News | Follow @JohnCFierce
@DamianFierce: it is with solemn humility that I now accept the mantle of Biotech's Bad Boy. thank you. | Follow @DamianFierce
> Gene therapy player Spark Therapeutics raised $94 million in a follow-on offering. Release
> Cambridge, MA-based Evelo Therapeutics has cut the ribbon on its new 9,000-square-foot HQ. The Flagship portfolio company--focused on the microbiome--was launched a few weeks ago with a $35 million round. Release
Medical Device News
@FierceMedDev: NYU researchers roll out ResearchKit app as part of concussion-monitoring study. Article | Follow @FierceMedDev
@EmilyWFierce: In this week's Dx Digest, $ILMN makes waves in China and $LH buys a women's health lab. More | Follow @EmilyWFierce
> VA signs onto ReWalk Robotics' exoskeleton device for paralyzed veterans. Report
> Australian teams aims to create dialysis-like blood filtration system to treat cancer. Article
> Startup touts first-in-man study of its sensor for cardiac ablation catheters in hopes of partnership. Story
Pharma News
@FiercePharma: Toxin from sea algae impacts memory, behavior in California sea lions: Study. More from FierceAnimalHealth | Follow @FiercePharma
@EricPFierce: Mylan wants some payback for plants it bought from Strides that have been cited by FDA. FiercePharmaManufacturing story | Follow @EricPFierce
@CarlyHFierce: AstraZeneca shrugs off pharma's emerging markets slowdown, but Lilly's suffering. Article | Follow @CarlyHFierce
> GSK's Avandia is free and clear at the FDA, 8 years after heart-safety controversy began. Story
> Top-earning directors on the S&P 500? Regeneron and Endo, at $1.4M and up. Report
> FBI arrests controversial Turing CEO Martin Shkreli on securities fraud charges. Article
CRO News
> PPD reportedly on the block for $8B. Report
> Recipharm signs on to manufacture an in-development cancer drug, investing in a Swedish biotech. Article
> On the rebound, AMRI trades $52M for a testing firm. News
Pharma Manufacturing News
> AstraZeneca shifts supply chain strategy from air to sea freight shipments. Report
> GSK opens Australia pilot plant to test blow-fill-seal technology on vaccines. Article
> WuXi and PRA canceling joint venture in China. Item
> Deadline looms to meet new label and insert requirements in Taiwan. More
> WuXi to sell AstraZeneca China's largest biologics plant for $100M. News
Pharma Asia News
> Indian healthcare IPOs raise $300M. Item
> Don't count India out yet in biosimilars race, Quintiles exec says. More
> YiChang IPO joins other drug companies in tough IPO market. Report
> Taiwan sets June 2016 deadline on new packaging, insert rules. Story
> WuXi venture unit raises $290M for 'find in U.S., build in China' venture fund. Article